text
"['\nIX. 계열회사 등에 관한 사항\n1. 타법인출자 현황\n(기준일 :\xa0\n2018년 12월 31일\n)\n(단위 : 백만원, 주, %)\n법인명\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n천진신풍제약유한공사\n1995.03.31\n-\n3,299\n-\n45.00\n3,299\n-\n-\n-\n-\n45.00\n3,299\n14,755\n-1,124\n신풍대우베트남파마(유)\n1996.10.14\n-\n7,402\n-\n96.58\n10,130\n-\n-\n-\n-\n96.58\n10,130\n12,859\n1,724\nGeneral Medicine Company Ltd.\n1988.02.28\n-\n742\n-\n33.33\n742\n-\n-\n-\n-\n33.33\n742\n24,402\n4,010\n필리핀신풍파마\n2002.08.26\n-\n95\n-\n80.00\n95\n-\n-\n-\n-\n80.00\n95\n1,450\n-246\nSP International\n2013.07.15\n-\n100\n-\n100.0\n1,062\n-\n-\n-\n-\n100.0\n1,062\n3,886\n-0\n미얀마신풍파마\n2014.07.17\n-\n51\n-\n100.0\n51\n-\n-\n-\n-\n100.0\n51\n379\n-162\n신풍USA\n2017.11.23\n-\n1,134\n100,000\n100.0\n1,134\n20,000\n215\n-\n120,000\n100.0\n1,349\n1,223\n-113\n씨바이오멕스\n2017.12.14\n-\n630\n67,000\n25.09\n630\n375,207\n200\n-\n442,207\n20.88\n830\n2,829\n-342\n합 계\n-\n-\n17,143\n-\n415\n-\n-\n-\n17,557\n61,783\n3,747\n* 최근 사업연도 재무현황은 2018년 기말 수치입니다.\n']"
